Improving Production of Tacrolimus In Streptomyces Tacrolimicus (ATCC 55098) Through Development of Novel Mutant by Dual Mutagenesis

AUTOR(ES)

Singh, Bhanu P, Kumar, Punit, Haque, Shafiul, Jawed, Arshad, Dubey, Kashyap Kumar

FONTE

Braz. arch. biol. technol.

DATA DE PUBLICAÇÃO

17/08/2017

RESUMO

ABSTRACT Tacrolimus is a polyketide macrolide produced by Streptomyces species which is widely used as anti-fibrotic agent and potent immunosuppressant. In this article dual mutagenesis approach using mutagens (NTG+EMS+UV) was used to develop a mutant strain of Streptomyces tacrolimicus (ATCC 55098) for higher tacrolimus production and this strain showed higher tacrolimus production at 82.5 mg/l. Interestingly; addition of L-Lysine (0.2 g/l) into the production medium further enhanced the tacrolimus production to ~102 mg/l at 7-L fed-batch bioreactor. To the best of our knowledge this is the first report mentioning efficient strain development for higher production of tacrolimus using dual mutagenesis. The obtained data presents an impressive model for higher production of tacrolimus and enhanced our understanding regarding improvement in production capacity of tacrolimus in Streptomyces tacrolimicus.

Documentos Relacionados

• Clavulanic acid production by the MMS 150 mutant obtained from wild type Streptomyces clavuligerus ATCC 27064
• Capsule structure of Proteus mirabilis (ATCC 49565).
• Histidine production by a regulatory mutant of Streptomyces coelicolor.
• Evaluation of different media for the production of cephalosporins by Streptomyces clavuligerus ATCC 27064
• Uso do açafrão (Curcuma longa L.) na redução da Escherichia coli (ATCC 25922) e Enterobacter aerogenes (ATCC 13048) em ricota